ASXC Asensus Surgical
- 0.2410
- -0.0040-1.63%
- 0.2469
- +0.0059+2.45%
Asensus Surgical News
12 Health Care Stocks Moving In Friday's After-Market Session
GainersNeuBase Therapeutics (NASDAQ:NBSE) stock increased by 11.1% to $0.45 during Friday's after-market session. The market value of their outstanding shares is at $1.6 million. Aptevo Therapeutics (
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersPulmonx (NASDAQ:LUNG) shares rose 29.5% to $10.0 during Wednesday's after-market session. The market value of their outstanding shares is at $388.1 million. The company's, Q1 earnings came out
Asensus Surgical Announces Sendai Tokushukai Hospital in Japan to Initiate Senhance Surgery Program
Second System to be Utilized by one of the Largest Private Hospital Systems in JapanRESEARCH TRIANGLE PARK, N.C., April 29, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a m
Wayfair To Rally Over 28%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Goldman Sa
Asensus Surgical Cut to Neutral From Buy by HC Wainwright & Co.
Asensus Surgical Cut to Neutral From Buy by HC Wainwright & Co.
HC Wainwright & Co. Downgrades Asensus Surgical to Neutral, Lowers Price Target to $0.35
HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Asensus Surgical from Buy to Neutral and lowers the price target from $2 to $0.35.
Sector Update: Health Care Stocks Rise Wednesday Afternoon
Health care stocks were advancing Wednesday afternoon, with the NYSE Health Care Index adding 0.3% and the Health Care Select Sector SPDR Fund (XLV) up 0.2%. The iShares Biotechnology ETF (IBB) decrea
Asensus Surgical Agrees To Karl Storz's Acquisition Offer; Stock Up
Asensus Surgical Agrees to Enter Diligence After Takeover Offer
By Will Feuer Asensus Surgical said it has entered into a non-binding letter of intent with Karl Storz, medical-technology company, to engage in diligence and negotiations regarding a takeover offer.
Press Release: Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement With KARL STORZ SE & Co. KG
Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG KARL STORZ to provide up to $20 million in bridge financing RESEARCH TRIANGL
Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement With KARL STORZ SE & Co. KG
KARL STORZ to provide up to $20 million in bridge financingRESEARCH TRIANGLE PARK, N.C., April 03, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) ("Asensus" or the "Company"),
Asensus Surgical Is Maintained at Buy by HC Wainwright & Co.
Asensus Surgical Is Maintained at Buy by HC Wainwright & Co.
HC Wainwright & Co. Maintains Buy on Asensus Surgical, Maintains $2 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Asensus Surgical with a Buy and maintains $2 price target.
Asensus Surgical Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/22/2024 715.66% HC Wainwright & Co. $2 → $2 Maintains Buy 11/16/2023 — Cantor Fitzgerald Downgrades Ov
Buy Rating Affirmed on Asensus Surgical Amidst Growth and Expansion Prospects
Earnings Call Summary | Asensus Surgical(ASXC.US) Q4 2023 Earnings Conference
The following is a summary of the Asensus Surgical, Inc. (ASXC) Q4 2023 Earnings Call Transcript:Financial Performance:Asensus reported a Q4 revenue of $5.4 million, a significant increase from $2.5 m
Recap: Asensus Surgical Q4 Earnings
Asensus Surgical (AMEX:ASXC) reported its Q4 earnings results on Thursday, March 21, 2024 at 04:05 PM.Here's what investors need to know about the announcement.EarningsAsensus Surgical beat estimated
Asensus Surgical Intends to File Annual Report on Form 10-K on or About March 21 >ASXC
Asensus Surgical Intends to File Annual Report on Form 10-K on or About March 21 >ASXC
Asensus Surgical: Audited Fincl Statements Will Contain Going Concern Paragraph >ASXC
Asensus Surgical: Audited Fincl Statements Will Contain Going Concern Paragraph >ASXC
Asensus Surgical Anticipates Available Cash Will Now Sustain Ops Until Early June
Asensus Surgical Anticipates Available Cash Will Now Sustain Ops Until Early June
Analysis
Price Target
No Data
